2026 · 3rd Quarter (July 1 - Sep 30)

EMD SERONO INC.

Filed by TODD STRATEGY GROUP.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 19, 2026
Income: $50,000.00
Expenses: Not reported
Registrant: TODD STRATEGY GROUP
Client: EMD SERONO INC.
Filing UUID: 0b4e6f35-234e-40b1-9fd6-d4120c68dcd1
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

P.L.119-21 (H.R. 1): One Big Beautiful Bill Act. H.R.946: Orphan CURES Act. S.864: HELP Copays Act; all provisions. S.1862: Orphan CURES Act; all provisions. Executive Order 14216: Expanding Access to In Vitro Fertilization. Executive Order 14297: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients. Pharmacy Benefit Manager (PBM) policy issues. Healthcare supply chain policy issues. Drug pricing. General discussions related to caregiving support and awareness policy issues. Biopharmaceutical innovation.

Literal federal measure citations: H.R. 1, H.R.946, S.864, S.1862

TRD · Trade (domestic/foreign)

Discussions related to tariffs and trade. Discussions related to critical minerals access.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.